Germany· DE-A57-cd6c9141f8cde1da
Piroxicam Abz
A piroxicam product containing piroxicam, registered in Germany by Abz-Pharma Gmbh. The same ATC class is registered in 11 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Piroxicam is registered in 11 of 19 countries.
Countries holding a registration under ATC M01AC01 (piroxicam), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 8 of them publish a price we can compare per daily dose
Piroxicam · ATC M01AC01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Italyprice
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of piroxicam costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.11 in Italy to $0.68 in Switzerland — a ×6.3 gap.
- 5 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Piroxicam · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.68
- US United States$0.27 (acquisition cost)
- FR France$0.18
- ES Spain$0.18
- IT Italy$0.11
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Piroxicam
- Manufacturer
- Abz-Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- M01AC01
- ATC class
- Piroxicam
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
354 interactions on record for piroxicam.
Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Piroxicam · interactions on record
354 records
- 57 severe
- 155 moderate
- 5 minor
- 68 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
69 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Piroxicam in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBrexidol 20mg tabletsWaymade Healthcare Plc
- United StatesPiroxicamBryant Ranch Prepack
- BelgiumBrexine 20 mgPI Pharma
- FinlandBrexidolOy Leiras Finland Ab
- ItalyBREXINPROMEDICA S.R.L.
- FranceFELDENE 20 mg, gélulePFIZER HOLDING FRANCE
- SpainFELDEGEL 5 mg/g GELPfizer S.L.
- PolandFeldeneInPharm Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Felden Quick-Solve
- Belgium · Brexine, Brexine-Dryfiz
- Bulgaria · Пироксикам Екофарм, Пироксикам Софарма
- Cyprus · Brexin, Feldene
- Czechia · Flamexin
- Estonia · Brexin
- Spain · Piroxicam Cinfa, Salvacam
- Finland · Piroxin
- France · Brexin, Cycladol
- United Kingdom (Northern Ireland) · Feldene, Feldene Melt
- Greece · Brexin, Brexin Dref
- Croatia · Lubor, Luboreta
- Hungary · Brexin
- Italy · Brexidol Unidie, Brexin
- Lithuania · Brexin
- Luxembourg · Brexine, Brexine-Dryfiz
- Latvia · Brexin
- Norway · Brexidol, Piroxicam Viatris
- Poland · Flamexin, Piroxicam Jelfa
- Portugal · Flexar, Piroxicam Pensavital
- Romania · Flamexin, Piroxicam
- Sweden · Brexidol
- Slovakia · Flamexin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/62dc7c0d-e714-45af-877b-f1a73058c3b9 GET /v1/drugs/62dc7c0d-e714-45af-877b-f1a73058c3b9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Piroxicam",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about piroxicam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.